Albizia for Mood Support

Research suggests that Albizia julibrissin, particularly its bark and flowers, has been studied for potential mood-supporting properties including antidepressant and anxiolytic effects, with the existing body of evidence drawing primarily from preclinical animal studies, mechanistic investigations, and narrative reviews rather than human clinical trials. Studies indicate several plausible biological mechanisms, including inhibition of the serotonin transporter by lignan glycosides, modulation of the cAMP-PKA-CREB signaling pathway, and effects on monoamine neurotransmitter systems broadly implicated in mood regulation. The available literature is consistently supportive in direction, and broader reviews of plant-based antidepressants and anxiolytics have included Albizia species among botanicals showing meaningful preclinical promise, though Albizia appears as a supporting rather than central focus in many of these wider reviews. The most significant limitation across this evidence base is the near-complete absence of controlled human trials, meaning that while the mechanistic rationale is reasonably developed, translation to demonstrated clinical benefit in people remains to be established.